COVID-19 and Tuberculosis: Unveiling the Dual Threat and Shared Solutions Perspective

The year 2020 will likely be remembered as the year dominated by COVID-19, or coronavirus disease. The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), responsible for this pandemic, can be traced back to late 2019 in China. The COVID-19 pandemic has significantly impacted...

Full description

Bibliographic Details
Main Authors: Ramona Cioboata, Viorel Biciusca, Mihai Olteanu, Corina Maria Vasile
Format: Article
Language:English
Published: MDPI AG 2023-07-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:https://www.mdpi.com/2077-0383/12/14/4784
_version_ 1797588838536708096
author Ramona Cioboata
Viorel Biciusca
Mihai Olteanu
Corina Maria Vasile
author_facet Ramona Cioboata
Viorel Biciusca
Mihai Olteanu
Corina Maria Vasile
author_sort Ramona Cioboata
collection DOAJ
description The year 2020 will likely be remembered as the year dominated by COVID-19, or coronavirus disease. The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), responsible for this pandemic, can be traced back to late 2019 in China. The COVID-19 pandemic has significantly impacted the tuberculosis (TB) care system, reducing TB testing and reporting. This can be attributed to the disruption of TB services and restrictions on patient movement, consequently increasing TB-related deaths. This perspective review aims to highlight the intersection between COVID-19 and TB, highlighting their dual threat and identifying shared solutions to address these two infectious diseases effectively. There are several shared commonalities between COVID-19 and tuberculosis, particularly the transmission of their causative agents, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and Mycobacterium tuberculosis. Both pathogens are transmitted via respiratory tract secretions. TB and COVID-19 are diseases that can be transmitted through droplets and airborne particles, and their primary target is typically the lungs. Regarding COVID-19 diagnostics, several methods are available for rapid and accurate detection. These include RT-PCR, which can provide results within two hours, and rapid antigen test kits that offer results in just a few minutes. The availability of point-of-care self-testing further enhances convenience. On the other hand, various approaches are employed for TB diagnostics to swiftly identify active TB. These include sputum microscopy, sputum for reverse transcription polymerase chain reaction (RT-PCR), and chest X-rays. These methods enable the rapid detection of active TB on the same day, while culture-based testing may take significantly longer, ranging from 2 to 8 weeks. The utilization of diverse diagnostic tools helps ensure the timely identification and management of COVID-19 and TB cases. The quality of life of patients affected by COVID-19 and tuberculosis (TB) can be significantly impacted due to the nature of these diseases and their associated challenges. In conclusion, it is crucial to emphasize the urgent need to address the dual threat of COVID-19 and TB. Both diseases have devastated global health, and their convergence poses an even greater challenge. Collaborative efforts, research investments, and policy reforms are essential to tackle this dual threat effectively.
first_indexed 2024-03-11T00:57:49Z
format Article
id doaj.art-7bbd0a09e7bc41fd8a01178306f55fc0
institution Directory Open Access Journal
issn 2077-0383
language English
last_indexed 2024-03-11T00:57:49Z
publishDate 2023-07-01
publisher MDPI AG
record_format Article
series Journal of Clinical Medicine
spelling doaj.art-7bbd0a09e7bc41fd8a01178306f55fc02023-11-18T19:53:55ZengMDPI AGJournal of Clinical Medicine2077-03832023-07-011214478410.3390/jcm12144784COVID-19 and Tuberculosis: Unveiling the Dual Threat and Shared Solutions PerspectiveRamona Cioboata0Viorel Biciusca1Mihai Olteanu2Corina Maria Vasile3Department of Pneumology, University of Pharmacy and Medicine Craiova, 200349 Craiova, RomaniaDepartment of Pneumology, University of Pharmacy and Medicine Craiova, 200349 Craiova, RomaniaDepartment of Pneumology, University of Pharmacy and Medicine Craiova, 200349 Craiova, RomaniaDepartment of Pediatric and Adult Congenital Cardiology, Bordeaux University Hospital, 33600 Pessac, FranceThe year 2020 will likely be remembered as the year dominated by COVID-19, or coronavirus disease. The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), responsible for this pandemic, can be traced back to late 2019 in China. The COVID-19 pandemic has significantly impacted the tuberculosis (TB) care system, reducing TB testing and reporting. This can be attributed to the disruption of TB services and restrictions on patient movement, consequently increasing TB-related deaths. This perspective review aims to highlight the intersection between COVID-19 and TB, highlighting their dual threat and identifying shared solutions to address these two infectious diseases effectively. There are several shared commonalities between COVID-19 and tuberculosis, particularly the transmission of their causative agents, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and Mycobacterium tuberculosis. Both pathogens are transmitted via respiratory tract secretions. TB and COVID-19 are diseases that can be transmitted through droplets and airborne particles, and their primary target is typically the lungs. Regarding COVID-19 diagnostics, several methods are available for rapid and accurate detection. These include RT-PCR, which can provide results within two hours, and rapid antigen test kits that offer results in just a few minutes. The availability of point-of-care self-testing further enhances convenience. On the other hand, various approaches are employed for TB diagnostics to swiftly identify active TB. These include sputum microscopy, sputum for reverse transcription polymerase chain reaction (RT-PCR), and chest X-rays. These methods enable the rapid detection of active TB on the same day, while culture-based testing may take significantly longer, ranging from 2 to 8 weeks. The utilization of diverse diagnostic tools helps ensure the timely identification and management of COVID-19 and TB cases. The quality of life of patients affected by COVID-19 and tuberculosis (TB) can be significantly impacted due to the nature of these diseases and their associated challenges. In conclusion, it is crucial to emphasize the urgent need to address the dual threat of COVID-19 and TB. Both diseases have devastated global health, and their convergence poses an even greater challenge. Collaborative efforts, research investments, and policy reforms are essential to tackle this dual threat effectively.https://www.mdpi.com/2077-0383/12/14/4784COVID-19tuberculosisdual-threatquality of lifepandemicperspective
spellingShingle Ramona Cioboata
Viorel Biciusca
Mihai Olteanu
Corina Maria Vasile
COVID-19 and Tuberculosis: Unveiling the Dual Threat and Shared Solutions Perspective
Journal of Clinical Medicine
COVID-19
tuberculosis
dual-threat
quality of life
pandemic
perspective
title COVID-19 and Tuberculosis: Unveiling the Dual Threat and Shared Solutions Perspective
title_full COVID-19 and Tuberculosis: Unveiling the Dual Threat and Shared Solutions Perspective
title_fullStr COVID-19 and Tuberculosis: Unveiling the Dual Threat and Shared Solutions Perspective
title_full_unstemmed COVID-19 and Tuberculosis: Unveiling the Dual Threat and Shared Solutions Perspective
title_short COVID-19 and Tuberculosis: Unveiling the Dual Threat and Shared Solutions Perspective
title_sort covid 19 and tuberculosis unveiling the dual threat and shared solutions perspective
topic COVID-19
tuberculosis
dual-threat
quality of life
pandemic
perspective
url https://www.mdpi.com/2077-0383/12/14/4784
work_keys_str_mv AT ramonacioboata covid19andtuberculosisunveilingthedualthreatandsharedsolutionsperspective
AT viorelbiciusca covid19andtuberculosisunveilingthedualthreatandsharedsolutionsperspective
AT mihaiolteanu covid19andtuberculosisunveilingthedualthreatandsharedsolutionsperspective
AT corinamariavasile covid19andtuberculosisunveilingthedualthreatandsharedsolutionsperspective